Investors Presentation on unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30 2026
01-Aug-2026
Download PDF
Concord Biotech
Investors Presentation on unaudited Standalone and Consolidated Financial Results for the first quarter ended June 30 2026